GLMD Galmed Pharmaceuticals posts wider than expected Q4 2025 loss while shares rise nearly 2 percent Why Byline BY looks solid from every angle Institutional Selling 20260511 MPWR Monolithic shares rise 153 percent despite small Q4 2025 EPS miss on 264 percent annual revenue growth How Lument LFTA earnings power stacks up historically LFTA Q3 Earnings Lument Series A Cumulative Preferred Stock Declares Dividend NUTX Nutex Health posts 824 percent year over year revenue growth shares edge higher despite large EPS miss